Hexagon Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-823
| Closed | -$680K | – | 1002 |
|
2025
Q1 | $680K | Sell |
823
-35
| -4% | -$28.9K | 0.13% | 77 |
|
2024
Q4 | $663K | Buy |
858
+155
| +22% | +$120K | 0.12% | 79 |
|
2024
Q3 | $623K | Sell |
703
-41
| -6% | -$36.3K | 0.12% | 78 |
|
2024
Q2 | $673K | Buy |
744
+24
| +3% | +$21.7K | 0.15% | 75 |
|
2024
Q1 | $560K | Buy |
720
+81
| +13% | +$63K | 0.12% | 88 |
|
2023
Q4 | $372K | Buy |
639
+51
| +9% | +$29.7K | 0.09% | 116 |
|
2023
Q3 | $316K | Sell |
588
-47
| -7% | -$25.2K | 0.08% | 117 |
|
2023
Q2 | $298K | Sell |
635
-5
| -0.8% | -$2.34K | 0.08% | 119 |
|
2023
Q1 | $220K | Buy |
640
+7
| +1% | +$2.41K | 0.06% | 151 |
|
2022
Q4 | $232K | Buy |
633
+28
| +5% | +$10.3K | 0.07% | 139 |
|
2022
Q3 | $196K | Buy |
605
+60
| +11% | +$19.4K | 0.06% | 146 |
|
2022
Q2 | $177K | Sell |
545
-198
| -27% | -$64.3K | 0.05% | 180 |
|
2022
Q1 | $213K | Sell |
743
-47
| -6% | -$13.5K | 0.06% | 175 |
|
2021
Q4 | $218K | Sell |
790
-93
| -11% | -$25.7K | 0.06% | 172 |
|
2021
Q3 | $204K | Buy |
883
+83
| +10% | +$19.2K | 0.06% | 155 |
|
2021
Q2 | $184K | Sell |
800
-100
| -11% | -$23K | 0.05% | 160 |
|
2021
Q1 | $168K | Sell |
900
-560
| -38% | -$105K | 0.05% | 152 |
|
2020
Q4 | $246K | Sell |
1,460
-70
| -5% | -$11.8K | 0.07% | 109 |
|
2020
Q3 | $201K | Buy |
+1,530
| New | +$201K | 0.06% | 112 |
|